- Home
- DTSS vs IBO Comparison
DTSS vs IBO Comparison
Compare DTSS & IBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DTSS
- IBO
- Stock Information
- Founded
- DTSS 2014
- IBO 2018
- Country
- DTSS China
- IBO United States
- Employees
- DTSS N/A
- IBO N/A
- Industry
- DTSS Computer Software: Prepackaged Software
- IBO
- Sector
- DTSS Technology
- IBO
- Exchange
- DTSS Nasdaq
- IBO NYSE
- Market Cap
- DTSS 16.5M
- IBO 5.8M
- IPO Year
- DTSS N/A
- IBO 2024
- Fundamental
- Price
- DTSS $2.06
- IBO $0.64
- Analyst Decision
- DTSS
- IBO
- Analyst Count
- DTSS 0
- IBO 0
- Target Price
- DTSS N/A
- IBO N/A
- AVG Volume (30 Days)
- DTSS 46.8K
- IBO 23.5M
- Earning Date
- DTSS 05-14-2025
- IBO 08-23-2025
- Dividend Yield
- DTSS N/A
- IBO N/A
- EPS Growth
- DTSS N/A
- IBO N/A
- EPS
- DTSS N/A
- IBO N/A
- Revenue
- DTSS $56,255,129.00
- IBO N/A
- Revenue This Year
- DTSS N/A
- IBO N/A
- Revenue Next Year
- DTSS N/A
- IBO N/A
- P/E Ratio
- DTSS N/A
- IBO N/A
- Revenue Growth
- DTSS 144.20
- IBO N/A
- 52 Week Low
- DTSS $1.63
- IBO $0.36
- 52 Week High
- DTSS $3.55
- IBO $6.17
- Technical
- Relative Strength Index (RSI)
- DTSS 52.48
- IBO N/A
- Support Level
- DTSS $1.89
- IBO N/A
- Resistance Level
- DTSS $2.08
- IBO N/A
- Average True Range (ATR)
- DTSS 0.10
- IBO 0.00
- MACD
- DTSS 0.01
- IBO 0.00
- Stochastic Oscillator
- DTSS 87.73
- IBO 0.00
About DTSS Datasea Inc.
Datasea Inc is a technology company. Its offers provides acoustic business services (focusing on high-tech acoustic technologies and applications such as ultrasound, infrasound, and Schumann resonance), 5G application services (5G AI multimodal digital business), and other products and services to various corporate and individual customers. The business activity of the group functions through China.
About IBO IMPACT BIOMEDICAL INC
Impact BioMedical Inc focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune-related diseases. The company is also developing open-air defense initiatives, which curb transmission of air-borne infectious diseases, such as tuberculosis and influenza. Its technologies inlcude Linebacker, Laetose, 3F, and Equivir.